In prostate cancer (PrCa), ST6GAL1 levels are elevated in patient plasma [11], and ST6GAL1 expression positively correlates with Gleason score, seminal vesicle involvement, and poor survival [12]. The gene discussed is ST6GAL1; the disease is pure red-cell aplasia.